GlaxoSmithKline S.A.E announced consolidated and standalone earnings results for the six months ended June 30, 2018. For the period, on consolidated basis, the company’s net profit was EGP 60,165,887 compared with net comparative profit of EGP 103,866,710 a year ago. For the period, on standalone basis, the company’s net profit was EGP 57,030,094 compared with net comparative profit of EGP 101,679,200 a year ago.